{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:08:36Z","timestamp":1755907716390,"version":"3.44.0"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1097\/xcs.0000000000000892","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T08:00:25Z","timestamp":1701763225000},"page":"311-312","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Invited Commentary: Path to Omission of Axillary Surgery after Neoadjuvant Therapy for Breast Cancer"],"prefix":"10.1097","volume":"238","author":[{"given":"Stephen B","family":"Edge","sequence":"first","affiliation":[{"name":"Buffalo, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"key":"R1-20250822","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/XCS.0000000000000916","article-title":"Axillary nodal response to neoadjuvant T-DM1 combined with pertuzumab in a prospective phase II multi-institution clinical trial.","volume":"238","author":"Weiss","year":"2024","journal-title":"J Am Coll Surg"},{"key":"R2-20250822","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1158\/2159-8290.CD-20-1557","article-title":"Impact of HER2 heterogeneity on treatment response of early-stage HER2-positive breast cancer: phase II neoadjuvant clinical trial of T-DM1 combined with pertuzumab.","volume":"11","author":"Filho","year":"2021","journal-title":"Cancer Discov"},{"key":"R3-20250822","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41523-022-00475-1","article-title":"MRI to assess response after neoadjuvant chemotherapy in breast cancer subtypes: a systematic review and meta-analysis.","volume":"8","author":"Janssen","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"R4-20250822","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/SLA.0000000000002313","article-title":"A clinical feasibility trial for identification of exceptional responders in whom breast cancer surgery can be eliminated following neoadjuvant systemic therapy.","volume":"267","author":"Kuerer","year":"2018","journal-title":"Ann Surg"},{"key":"R5-20250822","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S1470-2045(22)00613-1","article-title":"Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single arm, phase 2 trial.","volume":"23","author":"Kuerer","year":"2022","journal-title":"Lancet Oncol"},{"key":"R6-20250822","doi-asserted-by":"crossref","first-page":"e2300014","DOI":"10.1200\/GO.23.00014","article-title":"Accuracy of tumor bed biopsy for predicting pathologic complete response after chemotherapy among women with breast cancer: complete responders in the breast study.","volume":"9","author":"Hariharan","year":"2023","journal-title":"JCO Glob Oncol"},{"key":"R7-20250822","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1245\/s10434-021-10847-9","article-title":"Vacuum-assisted breast biopsy after neoadjuvant systemic treatment for reliable exclusion of residual cancer in breast cancer patients.","volume":"29","author":"Koelbel","year":"2022","journal-title":"Ann Surg Oncol"}],"container-title":["Journal of the American College of Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/XCS.0000000000000892","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T18:05:20Z","timestamp":1755885920000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/XCS.0000000000000892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/xcs.0000000000000892","relation":{},"ISSN":["1072-7515"],"issn-type":[{"type":"print","value":"1072-7515"}],"subject":[],"published":{"date-parts":[[2023,12,5]]}}}